Arrowhead Pharmaceuticals, Inc. (ARWR)
87.32
+1.10
(+1.28%)
USD |
NASDAQ |
Jul 30, 16:00
88.73
+1.41
(+1.61%)
After-Hours: 06:51
Arrowhead Pharmaceuticals Price to Book Value : 19.99 for July 30, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 30, 2026 | 19.99 |
| July 29, 2026 | 19.74 |
| July 28, 2026 | 19.64 |
| July 27, 2026 | 19.58 |
| July 24, 2026 | 19.60 |
| July 23, 2026 | 19.87 |
| July 22, 2026 | 20.31 |
| July 21, 2026 | 17.06 |
| July 20, 2026 | 16.40 |
| July 17, 2026 | 17.01 |
| July 16, 2026 | 16.34 |
| July 15, 2026 | 16.44 |
| July 14, 2026 | 16.46 |
| July 13, 2026 | 16.97 |
| July 10, 2026 | 17.49 |
| July 09, 2026 | 19.23 |
| July 08, 2026 | 19.63 |
| July 07, 2026 | 19.91 |
| July 06, 2026 | 19.82 |
| July 02, 2026 | 19.23 |
| July 01, 2026 | 18.42 |
| June 30, 2026 | 18.66 |
| June 29, 2026 | 18.43 |
| June 26, 2026 | 18.06 |
| June 25, 2026 | 18.15 |
| Date | Value |
|---|---|
| June 24, 2026 | 18.27 |
| June 23, 2026 | 18.29 |
| June 22, 2026 | 18.77 |
| June 18, 2026 | 18.73 |
| June 17, 2026 | 18.55 |
| June 16, 2026 | 17.53 |
| June 15, 2026 | 17.66 |
| June 12, 2026 | 17.06 |
| June 11, 2026 | 17.04 |
| June 10, 2026 | 16.19 |
| June 09, 2026 | 16.79 |
| June 08, 2026 | 16.91 |
| June 05, 2026 | 16.73 |
| June 04, 2026 | 17.21 |
| June 03, 2026 | 16.61 |
| June 02, 2026 | 16.21 |
| June 01, 2026 | 17.22 |
| May 29, 2026 | 17.84 |
| May 28, 2026 | 18.10 |
| May 27, 2026 | 18.08 |
| May 26, 2026 | 18.01 |
| May 22, 2026 | 17.16 |
| May 21, 2026 | 17.30 |
| May 20, 2026 | 17.66 |
| May 19, 2026 | 16.75 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics, Inc. | 1.091 |
| Denali Therapeutics, Inc. | 4.172 |
| Twist Bioscience Corp. | 12.47 |
| Revolution Medicines, Inc. | 25.65 |
| ImmunityBio, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 19.58 |
| PEG Ratio | -0.7271 |
| Price | 87.32 |
| Earnings Yield | -2.46% |
| Market Cap | 12.27B |
| PEGY Ratio | -0.7271 |